SS
BCDA icon

SBI Securities’s BioCardia BCDA Stock Holding History

SBI Securities’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11 Buy
9
+3
+50% +$4 ﹤0.01% 3837
2025
Q4 		$8 Sell
6
-1
-14% -$1 ﹤0.01% 3889
2025
Q3 		$9 Buy
7
+1
+17% +$2 ﹤0.01% 4038
2025
Q2 		$12 Sell
6
-2
-25% -$4 ﹤0.01% 3981
2025
Q1 		$20 Sell
8
-7
-47% -$17 ﹤0.01% 3852
2024
Q4 		$33 Buy
+15
New +$35 ﹤0.01% 3723

Other funds holding BCDA

CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PP
Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SBI Securities's BCDA Position: Q1 2026 in Review

SBI Securities increased its BioCardia (BCDA) stake by 50% in Q1 2026, buying an estimated $4 and bringing the position to 9 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

SBI Securities first reported a position in BCDA in Q4 2024 and has held it in 6 quarters since. The position peaked at $33 in Q4 2024. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.

  • SBI Securities held 9 shares of BioCardia worth $11 as of Q1 2026.
  • SBI Securities bought 3 BioCardia shares in Q1 2026, an estimated $4.
  • BioCardia made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3837 holding.
  • SBI Securities first reported a position in BioCardia in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's BioCardia position peaked at $33 in Q4 2024.
  • 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.